Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 304 Results
Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity
June 12, 2024
Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
May 15, 2024
Page 1 of 31